Breathe away the fear: new study tests simple technique for heart transplant anxiety

NCT ID NCT07381023

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a guided breathing technique called heart rate variability biofeedback (HRVB) can reduce anxiety in 60 adults who are in the ICU waiting for a heart transplant. Participants will use a biofeedback device or app during a single session led by a trained clinician. The goal is to see if this simple, non-drug approach helps patients feel calmer and more in control during a very stressful time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Heart Rate Variability Biofeedback (HRVB) - a guided breathing technique using a biofeedback device or app

What this could lead to

If it works, this could offer a simple, drug-free way to help heart transplant candidates manage anxiety while in the ICU.

What could go wrong

This is a very small, early-stage study with only 60 participants. The intervention is a single session, so any benefits may be short-lived. Results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.